Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Amoxicillin
Drug ID BADD_D00129
Description Amoxicillin, or BRL-2333, is a penicillin G derivative first described in the literature in 1972.[A190648] Amoxicillin has similar activity to [penicillin] and [ampicillin], but leads to higher serum concentrations than ampicillin.[A190648] Amoxicillin was granted FDA approval on 18 January 1974.[L11644]
Indications and Usage For the treatment of infections of the ear, nose, and throat, the genitourinary tract, the skin and skin structure, and the lower respiratory tract due to susceptible (only b-lactamase-negative) strains of Streptococcus spp. (a- and b-hemolytic strains only), S. pneumoniae, Staphylococcus spp., H. influenzae, E. coli, P. mirabilis, or E. faecalis. Also for the treatment of acute, uncomplicated gonorrhea (ano-genital and urethral infections) due to N. gonorrhoeae (males and females).
Marketing Status Prescription; Discontinued
ATC Code J01CA04
DrugBank ID DB01060
KEGG ID D00229
MeSH ID D000658
PubChem ID 33613
TTD Drug ID D0F6EO
NDC Product Code 16714-299; 63187-729; 68071-2323; 67296-1126; 70882-114; 63187-335; 50090-0407; 70518-1413; 70934-672; 50090-1826; 65862-016; 72789-225; 72789-077; 63187-186; 72189-285; 55657-106; 0093-3109; 68071-1526; 68071-4734; 45865-594; 65862-707; 68788-9949; 68071-1675; 50090-1794; 67296-1659; 61919-716; 68071-1817; 70847-530; 70882-113; 61919-041; 63187-044; 16714-298; 68071-4548; 50090-4260; 72508-205; 68071-2364; 63187-043; 68788-7318; 68071-4953; 65862-014; 50090-1797; 68071-2397; 65862-071; 52115-001; 65862-015; 0143-9889; 63187-200; 50090-4929; 63629-7585; 57237-033; 50090-1513; 70518-2191; 68071-4851; 68071-4704; 0143-9887; 50090-2251; 0781-5061; 63187-343; 0143-9886; 55289-182; 68071-4920; 70518-2188; 53002-1369; 68071-4567; 68071-4982; 50090-4320; 43063-820; 70934-064; 53002-2160; 0143-9888; 65862-274; 63629-7582; 71205-266; 63629-7584; 0093-4160; 50090-1795; 66267-871; 50090-0404; 0093-4161; 53002-0130; 50090-1807; 68071-1760; 0143-9938; 59115-041; 0143-9939; 68071-4907; 71205-507; 68788-7414; 76420-003; 65862-706; 0781-6156; 67296-1156; 68071-5019; 68071-4064; 63187-262; 68071-4455; 63187-195; 70518-3234; 43063-341; 68071-4574; 0781-5060; 72789-075; 61919-401; 65862-017; 68071-5127; 0781-6041; 57237-028; 43063-563; 68788-9017; 53002-2091; 70518-2190; 50090-0713; 63187-027; 68071-3292; 68071-4698; 68071-2604; 50090-3516; 43063-915; 70518-3228; 50090-1086; 63629-7587; 50090-1347; 53002-2080; 0093-2264; 70847-550; 68788-9948; 68071-2423; 63187-029; 68788-6374; 0093-2267; 68071-2558; 71205-422; 0781-6157; 70518-3294; 42708-112; 50090-1511; 50090-0712; 50090-1796; 55289-020; 43063-574; 50090-0709; 72789-074; 50090-0858; 68071-1789; 57237-030; 68071-4468; 68071-1761; 68071-3343; 63629-7589; 68071-4581; 70934-054; 70934-038; 70934-033; 0781-2613; 42708-078; 70934-087; 57237-031; 61919-015; 0093-3107; 54348-550; 55657-101; 61919-623; 72789-078; 63187-399; 66267-993; 68788-9019; 55289-019; 0781-2020; 71205-035; 42708-076; 68071-2320; 50090-0301; 71205-177; 50090-1595; 76420-138; 0093-2268; 53002-2090; 50090-1512; 0143-9285; 61919-994; 72789-224; 50090-1596; 68071-5148; 68788-7141; 68071-4971; 50090-0303; 66267-994; 50090-0405; 63187-880; 71205-436; 68071-4086; 0093-2263; 42708-010; 70934-140; 68788-6369; 61919-135; 50090-5863; 68788-9018; 57237-029; 50090-0455; 61919-672; 70934-084; 76420-192; 68071-4969; 65862-070; 72508-225; 70934-310; 68071-5096; 68071-5109; 50090-4078; 59651-099; 67296-0986; 68071-4741; 50090-5880; 63629-7588; 50090-4325; 70934-154; 50090-0711; 63187-013; 63187-295; 68071-4796; 43063-885; 0093-4155; 76420-112; 50090-0714; 57237-032; 63187-325; 68071-4693; 50090-0406; 43063-017; 68788-7812; 0781-6039; 50090-1514; 63187-591; 70934-407; 68071-3119; 50090-5215; 50090-0411; 68071-1826; 68071-4724; 68788-7323; 50090-0288; 68071-4696
Synonyms Amoxicillin | Amoxycillin | Amoxicilline | Amoxicillin Monopotassium Salt | Hydroxyampicillin | Amoxicillin Sodium | Amoxicillin Monosodium Salt | Amoxicillin, (R*)-Isomer | Amoxicillin Anhydrous | Actimoxi | BRL-2333 | BRL 2333 | BRL2333 | Clamoxyl | Penamox | Clamoxyl Parenteral | Clamoxyl G.A. | Polymox | Trimox | Wymox | Amoxicillin Trihydrate | Amoxil
Chemical Information
Molecular Formula C16H19N3O5S
CAS Registry Number 26787-78-0
SMILES CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
HyperphosphatasaemiaC-C chemokine receptor type 9P51686T9787325998949
HyperphosphatasaemiaC-C chemokine receptor type 4P51679T0695525998949
HyperphosphatasaemiaC-X-C chemokine receptor type 3P49682T2531525998949
Liver injuryC-X-C chemokine receptor type 3P49682T2531525998949
Liver injuryC-C chemokine receptor type 9P51686T9787325998949
Liver injuryC-C chemokine receptor type 4P51679T0695525998949
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Hypertelorism of orbit15.11.05.004; 06.09.05.003; 03.11.05.0040.000020%Not Available
Macroglossia07.14.01.011; 03.04.09.0030.000061%Not Available
Maternal drugs affecting foetus18.03.03.009; 12.03.03.0060.000030%Not Available
Microgenia15.11.05.006; 03.11.05.0060.000030%Not Available
Micrognathia15.11.05.007; 03.11.05.0070.000020%Not Available
Neonatal respiratory distress syndrome18.04.10.003; 22.11.02.0100.000030%Not Available
Nephritis allergic20.05.01.018; 10.01.03.0440.000020%Not Available
Normal newborn18.08.06.0010.000020%Not Available
Pleocytosis17.02.05.0590.000020%Not Available
Respiratory rate increased13.15.01.0040.000040%Not Available
Small for dates baby18.04.02.0020.000030%Not Available
Threatened labour18.07.01.0090.000040%Not Available
Live birth18.08.02.0070.000091%Not Available
Tongue haemorrhage07.14.01.015; 24.07.02.0580.000030%Not Available
Pulmonary sepsis22.07.01.014; 11.01.11.0140.000008%Not Available
Lip erosion07.05.01.0160.000030%Not Available
Laryngeal discomfort22.02.05.0400.000020%Not Available
Clostridium difficile infection11.02.02.0090.000151%Not Available
Retinal neovascularisation24.03.07.015; 14.07.01.006; 06.10.01.013; 05.07.01.0060.000030%Not Available
Factor V inhibition01.01.02.0200.000020%Not Available
Allergy test positive13.06.03.0110.000020%Not Available
Subacute hepatic failure09.01.03.0110.000005%Not Available
Palatal oedema07.05.04.0080.000121%Not Available
Eosinophilic colitis07.08.01.019; 01.02.04.0150.000020%Not Available
Sopor19.02.04.002; 17.02.04.021--Not Available
Embolia cutis medicamentosa24.01.01.030; 12.07.03.052; 08.02.03.0520.000020%Not Available
Analgesic drug level increased13.17.01.0140.000081%Not Available
Binocular eye movement disorder06.05.02.017; 17.02.05.0520.000040%Not Available
Purulence11.01.08.0600.000005%Not Available
Tryptase increased13.06.03.0130.000020%Not Available
The 23th Page    First    Pre   23 24    Next   Last    Total 24 Pages